Seminars in Radiation Oncology
Volume 20, Issue 4 , Pages 232-240 , October 2010

Single Nucleotide Polymorphisms of DNA Repair Genes as Predictors of Radioresponse

  • Matthew B. Parliament, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Matthew Parliament, MD, Department of Radiation Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2
    • ,
  • David Murray, PhD

References 

  1. Barnett GC, West CM, Dunning AM. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer. 2009;9:134–142
  2. Popanda O, Marquardt JU, Chang-Claude J. Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat Res. 2009;667:58–69
  3. Andreassen CN, Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: A systematic review. Radiother Oncol. 2009;92:299–309
  4. Wang J, Richter KK, Sung CC. Upregulation and spatial shift in the localization of the mannose 6-phosphate/insulin-like growth factor II receptor during radiation enteropathy development in the rat. Radiother Oncol. 1999;50:205–213
  5. Bentzen SM. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702–713
  6. Leadon SA. Repair of DNA damage produced by ionizing radiation: A minireview. Semin Radiat Oncol. 1996;6:295–305
  7. Haimovitz-Friedman A. Radiation-induced signal transduction and stress response. Radiat Res. 1998;150:S102
  8. Murray D, Begg AD. DNA repair genes and radiosensitivity. In:  Panasci LC,  Alaoui-Jamali MA editor. DNA Repair in Cancer Therapy. Totawa, NJ: Humana Press; 2004;
  9. Brookes AJ. The essence of SNPs. Gene. 1999;234:177–186
  10. Stoneking M. Single nucleotide polymorphisms (From the evolutionary past). Nature. 2001;409:821–822
  11. Gabriel SB, Schaffner SF, Nguyen H. The structure of haplotype blocks in the human genome. Science. 2002;296:2225–2229
  12. Redon R, Ishikawa S, Fitch KR. Global variation in copy number in the human genome. Nature. 2006;444:444–454
  13. Suga T, Ishikawa A, Kohda M. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;69:685–693
  14. Suga T, Iwakawa M, Tsuji H. Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:808–813
  15. Hutchison CA. DNA sequencing: Bench to bedside and beyond. Nucleic Acids Res. 2007;35:6227–6237
  16. Clarke M, Collins R, Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106
  17. Andreassen CN, Alsner J, Overgaard M. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol. 2003;69:127–135
  18. Andreassen CN, Alsner J, Overgaard M. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM—A study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol. 2006;82:577–586
  19. Chang-Claude J, Popanda O, Tan XL. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005;11:4802–4809
  20. Brem R, Cox DG, Chapot B. The XRCC1 -77T->C variant: Haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis. 2006;27:2469–2474
  21. Giotopoulos G, Symonds RP, Foweraker K. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer. 2007;96:1001–1007
  22. Moullan N, Cox DG, Angèle S. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev. 2003;12:1168–1174
  23. Appleby JM, Barber JB, Levine E. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer. 1997;76:1546–1549
  24. Shayeghi M, Seal S, Regan J. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer. 1998;78:922–927
  25. Iannuzzi CM, Atencio DP, Green S. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys. 2002;52:606–613
  26. Ho AY, Fan G, Atencio DP, et al. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2007;69:677–684
  27. Andreassen CN, Overgaard J, Alsner J. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006;64:776–783
  28. Edvardsen H, Tefre T, Jansen L. Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. Radiol Oncol. 2007;2:25
  29. Murray D, Mirzayans R. Role of p53 in the repair of ionizing radiation-induced DNA damage. In:  Landseer BR editors. New Research on DNA Repair. Hauppauge, NY: Nova Science Publishers; 2007;
  30. Tan XL, Popanda O, Ambrosone CB. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat. 2006;97:255–262
  31. Chang-Claude J, Ambrosone CB, Lilla C. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer. 2009;100:1680–1686
  32. Badie C, Dziwura S, Raffy C. Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br J Cancer. 2008;98:1845–1851
  33. Pierce LJ, Strawderman M, Narod SA. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol. 2000;18:3360–3369
  34. Shanley S, McReynolds K, Ardern-Jones A. Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clin Cancer Res. 2006;12:7025–7032
  35. Cesaretti JA, Stock RG, Lehrer S. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys. 2005;61:196–202
  36. Cesaretti JA, Stock RG, Atencio DP. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2007;68:1410–1416
  37. Burri RJ, Stock RG, Cesaretti JA. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res. 2008;170:49–59
  38. Pugh TJ, Keyes M, Barclay L. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients. Clin Cancer Res. 2009;15:5008–5016
  39. Damaraju S, Murray D, Dufour J. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res. 2006;12:2545–2554
  40. Werbrouck J, De Ruyck K, Duprez F. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: Influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys. 2009;73:1187–1195
  41. Kornguth DG, Garden AS, Zheng Y. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys. 2005;62:665–671
  42. De Ruyck K, Van Eijkeren M, Claes K. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys. 2005;62:1140–1149
  43. Carles J, Monzo M, Amat M. Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with stage I to II head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;66:1022–1030
  44. Tu HF, Chen HW, Kao SY. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol. 2008;87:243–252
  45. Wu X, Gu J, Wu TT. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006;24:3789–3798
  46. Warnecke-Eberz U, Vallböhmer D, Alakus H. ERCC1 And XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer. J Gastrointest Surg. 2009;13:1411–1421
  47. Yoon SM, Hong YC, Park HJ. The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:885–891
  48. Okazaki T, Jiao L, Chang P. Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. Clin Cancer Res. 2008;14:2042–2048
  49. Sakano S, Wada T, Matsumoto H. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br J Cancer. 2006;95:561–570
  50. Angèle S, Romestaing P, Moullan N. ATM haplotypes and cellular response to DNA damage: Association with breast cancer risk and clinical radiosensitivity. Cancer Res. 2003;63:8717–8725

 Supported in part by an operating grant to MBP from the Alberta Cancer Research Institute, Alberta, Canada.

PII: S1053-4296(10)00037-8

doi: 10.1016/j.semradonc.2010.05.003

Seminars in Radiation Oncology
Volume 20, Issue 4 , Pages 232-240 , October 2010

Article Tools